Structure and synthesis of a lipid-containing bacteriophage. 8. Effect of nalidixic acid on some membrane-associated activities of control and infected cells.
D000225:Adenine / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism*; D001435:Bacteriophages / Q000032:analysis / Q000378:metabolism* / Q000472:pathogenicity; D002247:Carbon Isotopes; D002462:Cell Membrane / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D004269:DNA, Bacterial / Q000096:biosynthesis; D004279:DNA, Viral / Q000096:biosynthesis*; D005374:Filtration; D009243:NAD; D009268:Nalidixic Acid / Q000494:pharmacology*; D010088:Oxidoreductases / Q000378:metabolism*; D010649:Phenylalanine / Q000378:metabolism; D010743:Phospholipids / Q000032:analysis; D011549:Pseudomonas / Q000187:drug effects / Q000201:enzymology* / Q000254:growth & development / Q000378:metabolism; D012329:RNA, Bacterial / Q000096:biosynthesis; D013385:Succinate Dehydrogenase / Q000378:metabolism*; D014316:Tritium
D002247:Carbon Isotopes; D004269:DNA, Bacterial; D004279:DNA, Viral; D010743:Phospholipids; D012329:RNA, Bacterial; D009243:NAD; D014316:Tritium; D009268:Nalidixic Acid; D010649:Phenylalanine; D010088:Oxidoreductases; D013385:Succinate Dehydrogenase; D000251:Adenosine Triphosphatases; D000225:Adenine